The first synthesis of the fungal natural product (-)-xylariamide A 1 is reported. N,O-
(-)-Xylariamide A 1, the previously synthesised (+)-xylariamide A 2 1 and (-)-dechloroxylariamide A 6 were all tested for cytotoxicity against the human cancer cell lines MCF-7 (breast), H460 (non small cell lung), and SF268 (CNS) using the colourimetric sulphorhodamine B assay. 8 Compounds 1, 2 and 6 showed no cytotoxicity after 72 h when tested at 5 and 50 μg/mL. Compounds 1, 2 and 6 were also tested against a panel of microbial strains known to be associated with nosocomial infection which included multi- Acinetobacter anitratus (wild type) and Candida albicans (ATCC 60193). Antimicrobial activities were evaluated using a broth micro dilution assay 9, 10 with each compound screened in a double dilution series from 500 to 1.0 μg/mL. No microbial growth inhibition was observed at any of these concentrations after 20 h of dosing.
In conclusion, this paper reports a simple synthesis of the fungal natural product (-)- 
